Display Settings:

Format

Send to:

Choose Destination
Ann Pharmacother. 2003 Sep;37(9):1266-75.

Atovaquone-proguanil for prophylaxis and treatment of malaria.

Author information

  • 1Faculty of Pharmaceutical Sciences, University of British Columbia, and Pharmacy and Vaccine Services, British Columbia Centre for Disease Control, Vancouver, Canada. fawziah.marra@bccdc.ca

Abstract

OBJECTIVE:

To review the currently available information on atovaquone-proguanil for treatment and prophylaxis of malaria.

DATA SOURCES:

A MEDLINE search was conducted from 1966 to February 2003 using key phrases Malarone, atovaquone, proguanil, and malaria. Further articles were identified from a manual search of the references of identified articles.

STUDY SELECTION AND DATA EXTRACTION:

English-language studies with animal and human data evaluating preclinical pharmacology, human studies on pharmacokinetics, and clinical trials were evaluated. Relevant data were extracted from identified articles.

DATA SYNTHESIS:

Atovaquone-proguanil has been evaluated for treatment of acute, uncomplicated malaria caused by Plasmodium falciparum in 8 clinical trials. In these studies, treatment with atovaquone-proguanil led to a higher (87-100% vs. 72-88%) or equally effective (94-100% vs. 90-100%) cure rate than the comparator antimalarial agents. Atovaquone-proguanil has been evaluated for prophylaxis of malaria in 6 clinical trials. In the 4 placebo-controlled trials for semi-immune residents or nonimmune migrants, the prophylaxis success rates in the atovaquone-proguanil and placebo arms ranged from 98% to 100% and 48% to 82%, respectively. The prophylaxis with success rates were similar among the 2 arms when atovaquone-proguanil was compared with other antimalarial regimens in nonimmune travelers. Atovaquone-proguanil was well tolerated in these clinical trials.

CONCLUSIONS:

Atovaquone-proguanil is a safe and effective alternative to current recommended regimens for prophylaxis and treatment of malaria.

PMID:
12921511
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk